ArticleFrontiers in oncology2021

Transcriptome Analysis Reveals MFGE8-HAPLN3 Fusion as a Novel Biomarker in Triple-Negative Breast Cancer.

Meng-Yuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.